v3.26.1
CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY - USD ($)
$ in Thousands
Total
Common Stock
Additional Paid-In Capital
Accumulated Deficit
Non-controlling Interest
Beginning balance (in shares) at Dec. 31, 2024   88,853,150      
Beginning balance at Dec. 31, 2024 $ 162,425 $ 889 $ 285,167 $ (123,868) $ 237
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income (28,909)     (28,658) (251)
Restricted stock grants (in shares)   309,915      
Restricted stock grants 0 $ 3 (3)    
Withholding of shares as payment of tax liabilities in connection with restricted stock vesting (in shares)   (35,590)      
Withholding of shares as payment of tax liabilities in connection with restricted stock vesting (86) $ (1) (85)    
Restricted stock grant canceled (in shares)   (404,374)      
Restricted stock grant cancelled 0 $ (4) 4    
Stock-based compensation 4,159   4,159    
Ending balance (in shares) at Jun. 30, 2025   88,723,101      
Ending balance at Jun. 30, 2025 137,589 $ 887 289,242 (152,526) (14)
Beginning balance (in shares) at Mar. 31, 2025   88,737,838      
Beginning balance at Mar. 31, 2025 158,176 $ 888 287,203 (129,853) (62)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income (22,625)     (22,673) 48
Restricted stock grants (in shares)   309,915      
Restricted stock grants 0 $ 3 (3)    
Withholding of shares as payment of tax liabilities in connection with restricted stock vesting (in shares)   (35,590)      
Withholding of shares as payment of tax liabilities in connection with restricted stock vesting (86) $ (1) (85)    
Restricted stock grant canceled (in shares)   (289,062)      
Restricted stock grant cancelled 0 $ (3) 3    
Stock-based compensation 2,124   2,124    
Ending balance (in shares) at Jun. 30, 2025   88,723,101      
Ending balance at Jun. 30, 2025 $ 137,589 $ 887 289,242 (152,526) (14)
Beginning balance (in shares) at Dec. 31, 2025 88,247,942 88,247,942      
Beginning balance at Dec. 31, 2025 $ 183,278 $ 883 291,716 (108,649) (672)
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income (19,010)     (19,010)  
Restricted stock grants (in shares)   2,788,640      
Restricted stock grants 0 $ 28 (28)    
Withholding of shares as payment of tax liabilities in connection with restricted stock vesting (in shares)   (15,609)      
Withholding of shares as payment of tax liabilities in connection with restricted stock vesting (30) $ (1) (29)    
Restricted stock grant canceled (in shares)   (130,500)      
Restricted stock grant cancelled 0 $ (1) 1    
Stock-based compensation 2,822   2,822    
Acquisition of subsidiary $ (100)   (772)   672
Ending balance (in shares) at Jun. 30, 2026 90,890,473 90,890,473      
Ending balance at Jun. 30, 2026 $ 166,960 $ 909 293,710 (127,659) 0
Beginning balance (in shares) at Mar. 31, 2026   88,117,442      
Beginning balance at Mar. 31, 2026 168,070 $ 882 292,113 (124,925) 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]          
Net (loss) income (2,734)     (2,734)  
Restricted stock grants (in shares)   2,788,640      
Restricted stock grants 0 $ 28 (28)    
Withholding of shares as payment of tax liabilities in connection with restricted stock vesting (in shares)   (15,609)      
Withholding of shares as payment of tax liabilities in connection with restricted stock vesting (30) $ (1) (29)    
Stock-based compensation $ 1,654   1,654    
Ending balance (in shares) at Jun. 30, 2026 90,890,473 90,890,473      
Ending balance at Jun. 30, 2026 $ 166,960 $ 909 $ 293,710 $ (127,659) $ 0